¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Complications specific to multiple gestation"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
multiple correlation
´ÙÁß»ó°ü
multiple division
º¹Çպп
multiple drug resistance
´Ù¾àÁ¦³»¼º, ¿©·¯¾àÀúÇ×
multiple embolism
´Ù¹ß»öÀüÁõ
multiple endocrine adenomatosis
´Ù¹ß¼º³»ºÐºñ»ùÁ¾Áõ
multiple endocrine neoplasia
´Ù¹ß³»ºÐºñ»ùÁ¾¾ç
multiple endocrine neoplasia 1
´Ù¹ß³»ºÐºñ»ùÁ¾¾ç1Çü
multiple endocrine neoplasia 2
´Ù¹ß³»ºÐºñ»ùÁ¾¾ç2Çü
multiple endocrine neoplasia 3
´Ù¹ß³»ºÐºñ»ùÁ¾¾ç3Çü
multiple epiphyseal dysplasia
¹µ»À³¡Çü¼ºÀÌ»ó, ´Ù¹ß°ñ´ÜÇü¼ºÀÌ»ó
multiple excitation
´Ù¹ßÈïºÐ
multiple fetation
´Ù¼öÀÓ½Å
multiple field irradiation
¿©·¯¿µ¿ªÁ¶»ç
multiple fission
¹µºÐ¿, ´ÙÁߺп
multiple fracture
´Ù¹ß°ñÀý
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
multiple correlation
´ÙÁß»ó°ü
multiple deformity
º¹ÇÕ±âÇü
multiple division
º¹Çպп
multiple dysplasia
¹µÇü¼ºÀå¾Ö
multiple personality disorder
´ÙÁßÀΰÝÀå¾Ö
hereditary multiple exostosis
À¯Àü´Ù¹ß»Àµ¹ÃâÁõ
multiple embolism
´Ù¹ß»öÀüÁõ
multiple epitheliomatosis
´Ù¹ß»óÇÇÁ¾Áõ
multiple excitation
¹Ýº¹ÈïºÐ
multiple fetation
´Ù¼öÀÓ½Å
multiple fission
¹µºÐ¿, ´Ù¼öºÐ¿
multiple fracture
´Ù¹ß°ñÀý
multiple sclerotic gait
´Ù¹ß°æÈÁõ°ÉÀ½
multiple infection
¿©·¯¹ø°¨¿°
multiple intussusception
´Ù¹ßâÀÚ°ãħÁõ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
polyembryonic gestation
¹µ¹èÀÚÀÓ½Å
SDA= specific dynamic action
ƯÀ̵¿Àû ÀÛ¿ë.
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
group-specific C carbohydrate
±ºÆ¯ÀÌ C ź¼öȹ°
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
group-specific antigen
±º-ƯÀÌÇ׿ø
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immunity, specific
ƯÀ̸鿪
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
gestation, anembryonic
¹«Å¾Ƽº ÀӽŠ(Ùí÷Ãä®àõ ìõãã)
late gestation
ÀÓ½ÅÈıâ(ìôããýÑ¢).
monoembryonic gestation
Ȭ¹èÀÚÀÓ½Å
polyembryonic gestation
¹µ¹èÀÚÀÓ½Å
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
blood group specific substance
Ç÷¾×ÇüƯÀ̹°Áú.
bulk specific gravity
¿ëÀûºñÁß(é»îÝÝïñì)
donor-specific phage
°ø¿©±ÕƯÀÌÆÄÁö
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½